How Timely is Canada’s Medication Review and Approval Process? Date held: January 24th, 2019 Presented by: Gerry Jeffcott, 3Sixty Public Affairs with Nigel Rawson & Sarah Lussier Webinar Information: This presentation was hosted by Gerry Jeffcott from 3Sixty Public Affairs, who was joined by two pharmaceutical policy researchers who have conducted analyses of Canada’s access performance over time and in comparison with other countries. The
Month: January 2019
Health Minister Unveils the Revised Canada Food Guide
Canada’s long-anticipated revised food guide was released Tuesday morning, and it has some big changes from previous guidance on healthy eating. As hinted at in public consultations and draft documents, the new guide does away with the four food groups and advice on the number of servings to eat each day – something even Health Canada says people found confusing in the last food guide.
Larotrectinib for TRK Gene Fusion-positive Cancer: Patient & Caregiver Survey Now Available
The Canadian Cancer Survivor Network, in participation with six fellow Canadian patient groups have developed a new patient & caregiver survey. The purpose of the survey is to provide the Canadian Cancer Survivor Network (CCSN) with insights and perspectives from patients and caregivers who are managing TRK gene fusion–positive cancers. This is in order to complete a patient evidence submission for a new targeted medication
Glyphosate Objectors’ Concerns Heightened by Health Canada Response
Glyphosate Objectors’ Concerns Are Heightened Following Replies from Health Canada (being released January 14, 2019 online) Responses Dismiss Key Science and Lack Transparency Canadians at Risk, With no Independent Review of Roundup Herbicide For Immediate Release Ottawa, January 14, 2018 – Today, Health Canada is releasing online, responses to eight objections to re-registration of glyphosate (the active ingredient in Roundup herbicide). Government responses leave
HHS discloses issue with a specific type of radiation therapy at the Juravinski Cancer Centre
In late November 2018, Hamilton Health Sciences discovered an issue with the equipment used to deliver brachytherapy (BT) to patients with cervical cancer. The only patients who may have been affected by this issue are those who received this specific kind of therapy – BT – for cervical cancer in 2017 and 2018. Physicians, nurses and other members of our team have met with the
Health Canada Announces Release of Drug and Medical Device Databases
December 27, 2018 Health Canada is pleased to announce the release of the document Drug and Medical Device Databases. This document provides a comprehensive list of Health Canada’s drug and medical device databases and includes an overview of the information available in each database. The guidelines are designed to facilitate access to these databases and to inform stakeholders on what information is available. Questions or